Key result
Percutaneous transluminal coronary angioplasty had a 36% lower 1-year cost than coronary bypass surgery (13,625 vs 21,363 Dfl), despite a higher 1-year reintervention rate (29% vs 2%).
Why the study?
Does PTCA compared to CABG result in lower 1-year costs in patients with angina pectoris?
Observational
Does PTCA compared to CABG result in lower 1-year costs in patients with angina pectoris?
Absolute Event Rate: 13625% vs 21363%
PTCA has lower initial and 1-year costs compared to CABG, but higher reintervention rates may equalize costs over a longer time span.
No takes yet. Share an insight, caveat, or question.
PTCA was associated with lower 1-year costs than CABG; leaves open long-term equivalence pending RCTs with extended follow-up.
BRAND et al. (1990) conducted an observational in Angina pectoris. Percutaneous transluminal coronary angioplasty (PTCA) vs. Coronary bypass surgery (CABG) was evaluated on 1-year cost (procedural plus reinterventions in Dfl). Percutaneous transluminal coronary angioplasty had a 36% lower 1-year cost than coronary bypass surgery (13,625 vs 21,363 Dfl), despite a higher 1-year reintervention rate (29% vs 2%).